• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肽YY(3-36)抑制下丘脑多巴胺和去甲肾上腺素的释放。

Peptide YY (3 -36) inhibits dopamine and norepinephrine release in the hypothalamus.

作者信息

Brunetti Luigi, Orlando Giustino, Ferrante Claudio, Chiavaroli Annalisa, Vacca Michele

机构信息

Department of Drug Sciences, G. D'Annunzio University, School of Pharmacy, via dei Vestini, 66013 Chieti, Italy.

出版信息

Eur J Pharmacol. 2005 Sep 5;519(1-2):48-51. doi: 10.1016/j.ejphar.2005.07.008.

DOI:10.1016/j.ejphar.2005.07.008
PMID:16095590
Abstract

Peptide YY (1-36) and peptide YY (3-36) are gut-derived hormones which are involved in feeding control in the hypothalamus. The hypothalamic mechanisms of feeding have been shown to be modulated by aminergic neurotransmitters, which could mediate the anorectic or orexigenic effects of neuropeptides and hormones. We have investigated the role of peptide YY (1-36) and peptide YY (3-36) on dopamine, norepinephrine, and serotonin release from hypothalamic synaptosomes in vitro. We found that peptide YY (3-36) inhibited depolarization-induced dopamine and norepinephrine release, leaving unaffected serotonin release, while peptide YY (1-36) did not modify either basal or stimulated amine release. We can hypothesize that the effects of peptide YY (3-36) could be mediated by inhibited hypothalamic dopamine and norepinephrine release, which could partially account for the anorectic activity of the peptide. On the other hand, peptide YY (1-36), which has a feeding stimulatory role, does not affect aminergic neurotransmission in the hypothalamus.

摘要

肽YY(1 - 36)和肽YY(3 - 36)是源自肠道的激素,参与下丘脑的进食控制。进食的下丘脑机制已被证明受胺能神经递质调节,胺能神经递质可介导神经肽和激素的厌食或促食欲作用。我们研究了肽YY(1 - 36)和肽YY(3 - 36)对体外下丘脑突触体中多巴胺、去甲肾上腺素和5-羟色胺释放的作用。我们发现肽YY(3 - 36)抑制去极化诱导的多巴胺和去甲肾上腺素释放,而不影响5-羟色胺释放,而肽YY(1 - 36)既不改变基础胺释放也不改变刺激后的胺释放。我们可以推测,肽YY(3 - 36)的作用可能是通过抑制下丘脑多巴胺和去甲肾上腺素释放介导的,这可能部分解释了该肽的厌食活性。另一方面,具有促进食作用的肽YY(1 - 36)不影响下丘脑的胺能神经传递。

相似文献

1
Peptide YY (3 -36) inhibits dopamine and norepinephrine release in the hypothalamus.肽YY(3-36)抑制下丘脑多巴胺和去甲肾上腺素的释放。
Eur J Pharmacol. 2005 Sep 5;519(1-2):48-51. doi: 10.1016/j.ejphar.2005.07.008.
2
Glucagon-like peptide 1 (7-36) amide (GLP-1) and exendin-4 stimulate serotonin release in rat hypothalamus.胰高血糖素样肽1(7-36)酰胺(GLP-1)和艾塞那肽-4可刺激大鼠下丘脑释放5-羟色胺。
Peptides. 2008 Aug;29(8):1377-81. doi: 10.1016/j.peptides.2008.04.007. Epub 2008 Apr 20.
3
Resistin, but not adiponectin, inhibits dopamine and norepinephrine release in the hypothalamus.抵抗素而非脂联素会抑制下丘脑多巴胺和去甲肾上腺素的释放。
Eur J Pharmacol. 2004 Jun 16;493(1-3):41-4. doi: 10.1016/j.ejphar.2004.04.020.
4
Obestatin inhibits dopamine release in rat hypothalamus.肥胖抑制素抑制大鼠下丘脑中多巴胺的释放。
Eur J Pharmacol. 2010 Sep 1;641(2-3):142-7. doi: 10.1016/j.ejphar.2010.05.059. Epub 2010 Jun 8.
5
Effects of ghrelin and amylin on dopamine, norepinephrine and serotonin release in the hypothalamus.胃饥饿素和胰淀素对下丘脑多巴胺、去甲肾上腺素和5-羟色胺释放的影响。
Eur J Pharmacol. 2002 Nov 15;454(2-3):189-92. doi: 10.1016/s0014-2999(02)02552-9.
6
Cocaine- and amphetamine-regulated transcript peptide-(55-102) and thyrotropin releasing hormone inhibit hypothalamic dopamine release.
Eur J Pharmacol. 2000 Dec 8;409(2):103-7. doi: 10.1016/s0014-2999(00)00783-4.
7
Orexigenic effects of omentin-1 related to decreased CART and CRH gene expression and increased norepinephrine synthesis and release in the hypothalamus.网膜素-1 可引起摄食增加,其作用机制可能与下丘脑中 CART 和 CRH 基因表达减少以及去甲肾上腺素合成和释放增加有关。
Peptides. 2013 Jun;44:66-74. doi: 10.1016/j.peptides.2013.03.019. Epub 2013 Mar 26.
8
Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin.苯丙胺类中枢神经系统兴奋剂释放去甲肾上腺素的作用比释放多巴胺和5-羟色胺的作用更强。
Synapse. 2001 Jan;39(1):32-41. doi: 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3.
9
Dose-related effects of cysteamine treatment on hypothalamic and striatal dopamine, noradrenaline and serotonin neurotransmission.半胱胺治疗对下丘脑和纹状体多巴胺、去甲肾上腺素及5-羟色胺神经传递的剂量相关效应。
Acta Physiol Hung. 1985;66(2):213-7.
10
Leptin inhibits norepinephrine and dopamine release from rat hypothalamic neuronal endings.
Eur J Pharmacol. 1999 May 21;372(3):237-40. doi: 10.1016/s0014-2999(99)00255-1.

引用本文的文献

1
Evaluation of Pharmacological and Phytochemical Profiles (Hook.f.) Brenan Stem Bark Extracts.评价(Hook.f.)Brenan 茎皮提取物的药理和植物化学特征。
Biomolecules. 2020 Mar 28;10(4):516. doi: 10.3390/biom10040516.
2
Neuroendocrinology of reward in anorexia nervosa and bulimia nervosa: Beyond leptin and ghrelin.神经性厌食症和神经性贪食症的奖赏神经内分泌学:超越瘦素和胃饥饿素。
Mol Cell Endocrinol. 2019 Nov 1;497:110320. doi: 10.1016/j.mce.2018.10.018. Epub 2018 Nov 2.
3
Monoamines differentially modulate neuropeptide release from distinct sites within a single neuron pair.
单胺类物质可从单个神经元对的不同部位调节神经肽的释放。
PLoS One. 2018 May 3;13(5):e0196954. doi: 10.1371/journal.pone.0196954. eCollection 2018.
4
Peptide YY Causes Apathy-Like Behavior via the Dopamine D2 Receptor in Repeated Water-Immersed Mice.肽 YY 通过多巴胺 D2 受体在反复浸水小鼠中引起类似冷漠的行为。
Mol Neurobiol. 2018 Sep;55(9):7555-7566. doi: 10.1007/s12035-018-0931-1. Epub 2018 Feb 10.
5
The role of "mixed" orexigenic and anorexigenic signals and autoantibodies reacting with appetite-regulating neuropeptides and peptides of the adipose tissue-gut-brain axis: relevance to food intake and nutritional status in patients with anorexia nervosa and bulimia nervosa.“混合性”促食欲和抑食欲信号以及与食欲调节神经肽和脂肪组织-肠道-脑轴肽类发生反应的自身抗体的作用:与神经性厌食症和神经性贪食症患者的食物摄入及营养状况的相关性
Int J Endocrinol. 2013;2013:483145. doi: 10.1155/2013/483145. Epub 2013 Sep 9.